These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10501411)

  • 1. The Sydney Blood Bank Cohort: a case-control study using a transfused HIV-1 seronegative group.
    McIntyre LB; Geczy AF; Dyer WB; Learmont JC; Sullivan JS
    Ann Epidemiol; 1999 Oct; 9(7):436-40. PubMed ID: 10501411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.
    Dyer WB; Geczy AF; Kent SJ; McIntyre LB; Blasdall SA; Learmont JC; Sullivan JS
    AIDS; 1997 Nov; 11(13):1565-74. PubMed ID: 9365760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
    Birch MR; Learmont JC; Dyer WB; Deacon NJ; Zaunders JJ; Saksena N; Cunningham AL; Mills J; Sullivan JS
    J Clin Virol; 2001 Oct; 22(3):263-70. PubMed ID: 11564591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals.
    Levin A; Brubaker G; Shao JS; Kumby D; O'Brien TR; Goedert JJ; Strauss KW; Blattner WA; Hannet I
    Int J STD AIDS; 1996 Jul; 7(4):288-91. PubMed ID: 8876362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.
    Plaeger-Marshall S; Isacescu V; O'Rourke S; Bertolli J; Bryson YJ; Stiehm ER
    Clin Immunol Immunopathol; 1994 Apr; 71(1):19-26. PubMed ID: 7511081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1.
    Pepin J; Morgan G; Dunn D; Gevao S; Mendy M; Gaye I; Scollen N; Tedder R; Whittle H
    AIDS; 1991 Oct; 5(10):1165-72. PubMed ID: 1786143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset.
    Nishanian P; Taylor JM; Manna B; Aziz N; Grosser S; Giorgi JV; Detels R; Fahey JL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):162-70. PubMed ID: 9637581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry.
    Ginaldi L; De Martinis M; D'Ostilio A; Di Gennaro A; Marini L; Quaglino D
    Am J Clin Pathol; 1997 Nov; 108(5):585-92. PubMed ID: 9353099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease.
    Giorgi JV
    Ann N Y Acad Sci; 1993 Mar; 677():126-37. PubMed ID: 8494202
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term HIV-1 infection without immunologic progression.
    Buchbinder SP; Katz MH; Hessol NA; O'Malley PM; Holmberg SD
    AIDS; 1994 Aug; 8(8):1123-8. PubMed ID: 7986410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell activation and disease severity in HIV infection.
    Mahalingam M; Peakman M; Davies ET; Pozniak A; McManus TJ; Vergani D
    Clin Exp Immunol; 1993 Sep; 93(3):337-43. PubMed ID: 8103715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation markers and AIDS prognosis.
    Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
    AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
    Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
    AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.
    Janossy G; Borthwick N; Lomnitzer R; Medina E; Squire SB; Phillips AN; Lipman M; Johnson MA; Lee C; Bofill M
    AIDS; 1993 May; 7(5):613-24. PubMed ID: 8318170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.